English  |  正體中文  |  简体中文  |  總筆數 :2854037  
造訪人次 :  45317222    線上人數 :  1005
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至: [ 中文 ] [ 數字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
請輸入前幾個字:   

顯示項目 550611-550620 / 2346788 (共234679頁)
<< < 55057 55058 55059 55060 55061 55062 55063 55064 55065 55066 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2009 Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis 孫幸筠; SUN, HSIN-YUN
臺大學術典藏 2018-09-10T07:19:59Z Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis Sun, H.-Y. and Alexander, B.D. and Lortholary, O. and Dromer, F. and Forrest, G.N. and Lyon, G.M. and Somani, J. and Gupta, K.L. and Del Busto, R. and Pruett, T.L. and Sifri, C.D. and Limaye, A.P. and John, G.T. and Klintmalm, G.B. and Pursell, K. and Stosor, V. and Morris, M.I. and Dowdy, L.A. and Munoz, P. and Kalil, A.C. and Garcia-Diaz, J. and Orloff, S. and House, A.A. and Houston, S. and Wray, D. and Huprikar, S. and Johnson, L.B. and Humar, A. and Razonable, R.R. and Husain, S. and Singh, N.; HSIN-YUN SUN
臺大學術典藏 2009 Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis Forrest G.N.; Dromer F.; Lortholary O.; Alexander B.D.; HSIN-YUN SUN; Houston S.; House A.A.; Orloff S.; Garcia-Diaz J.; Kalil A.C.; Munoz P.; Lyon G.M.; Somani J.; Gupta K.L.; Del Busto R.; Pruett T.L.; Sifri C.D.; Limaye A.P.; John G.T.; Klintmalm G.B.; Pursell K.; Stosor V.; Morris M.I.; Dowdy L.A.; Wray D.; Huprikar S.; Johnson L.B.; Humar A.; Razonable R.R.; Husain S.; Singh N.
臺大學術典藏 2018-09-10T14:51:58Z Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials Tebas, P. and Sension, M. and Arribas, J. and Duiculescu, D. and Florence, E. and Hung, C.-C. and Wilkin, T. and Vanveggel, S. and Stevens, M. and Deckx, H.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:38Z Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials Tebas P.; Sension M.; Arribas J.; Duiculescu D.; Florence E.; CHIEN-CHING HUNG; Wilkin T.; Vanveggel S.; Stevens M.; Deckx H.
臺大學術典藏 2022-09-09T05:50:01Z Lipid lowering in primary prevention: The lower is better, but where to settle? WEI-SHIUNG YANG
國立成功大學 2018-09 Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I
臺大學術典藏 2020-02-25T09:24:04Z Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C.
臺大學術典藏 2020-09-30T08:49:26Z Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators
臺大學術典藏 2021-03-18T08:54:16Z Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators

顯示項目 550611-550620 / 2346788 (共234679頁)
<< < 55057 55058 55059 55060 55061 55062 55063 55064 55065 55066 > >>
每頁顯示[10|25|50]項目